PHARMERICA CORP's ticker is PMC and the CUSIP is 71714F104. A total of 182 filers reported holding PHARMERICA CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $342,000 | -91.5% | 11,670 | -92.4% | 0.02% | -91.0% |
Q2 2017 | $4,025,000 | +5.0% | 153,340 | -6.4% | 0.20% | +10.5% |
Q1 2017 | $3,834,000 | -7.0% | 163,840 | 0.0% | 0.18% | -9.5% |
Q4 2016 | $4,121,000 | +44.1% | 163,840 | +60.8% | 0.20% | +36.1% |
Q3 2016 | $2,860,000 | +14.0% | 101,900 | +0.1% | 0.15% | +8.9% |
Q2 2016 | $2,509,000 | +348.8% | 101,790 | +302.8% | 0.14% | +264.9% |
Q1 2016 | $559,000 | +158.8% | 25,270 | +310.2% | 0.04% | +131.2% |
Q4 2015 | $216,000 | -91.4% | 6,160 | -93.9% | 0.02% | -83.3% |
Q3 2015 | $2,507,000 | +1212.6% | 101,610 | +1667.1% | 0.10% | +585.7% |
Q2 2015 | $191,000 | +18.6% | 5,750 | +0.9% | 0.01% | +16.7% |
Q1 2015 | $161,000 | +1.3% | 5,700 | -26.0% | 0.01% | +9.1% |
Q4 2014 | $159,000 | -93.2% | 7,700 | -91.9% | 0.01% | -93.8% |
Q3 2014 | $2,333,000 | -14.0% | 95,500 | +0.6% | 0.18% | -12.8% |
Q2 2014 | $2,713,000 | +2.2% | 94,900 | 0.0% | 0.20% | -1.9% |
Q1 2014 | $2,655,000 | – | 94,900 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Smith, Graham & Co., Investment Advisors, LP | 372,169 | $8,229,000 | 1.08% |
LOMBARDIA CAPITAL PARTNERS LLC | 839,636 | $18,564,000 | 0.96% |
Malaga Cove Capital, LLC | 45,139 | $998,000 | 0.82% |
Endurant Capital Management LP | 99,490 | $2,200,000 | 0.71% |
Phocas Financial Corp. | 262,430 | $5,802,000 | 0.45% |
Century Capital Management, LLC | 154,646 | $3,419,000 | 0.38% |
Personal Capital Advisors Corp | 325,099 | $7,188,000 | 0.33% |
FULLER & THALER ASSET MANAGEMENT, INC. | 718,292 | $15,881,000 | 0.31% |
ENDICOTT MANAGEMENT CO | 30,000 | $663,000 | 0.23% |
Convergence Investment Partners, LLC | 70,550 | $1,560,000 | 0.19% |